Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interleukin-1 receptor antagonist in severe traumatic brain injury
ISRCTN88597330Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Sep 2008
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised trial in traumatic brain injury (TBI) comparing Kineret with Placebo (2 arms). Primary endpoint: Safety. Started Sep 2008; status: completed.
02
Drugs
anakinra
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ISRCTN88597330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN88597330.